Annovis Bio (ANVS) — Institutional Investor Activity (Q2 2026)

ANVS ranks #5603 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

ANVS is a disclosed holding of Paul Tudor Jones (Tudor Investment Corp), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

ANVS is a top-conviction position for Empery Asset Management, LP — at 5.2% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

Sherry Group, Inc. has trimmed its ANVS position for two straight quarters, cutting it by $55.0K while still holding $72.7K.

ANVS is down 3% today, but institutions show net buying of $13.1M this quarter — a divergence between today's price move and the underlying institutional flow.

ANVS reported a net loss of $49.5M over the trailing twelve months.

• Not yet profitable — net loss of $49.5M over the trailing twelve months
• Net income declined year over year, from -$30.3M to -$49.5M
• Operating cash flow was negative, using $25.6M in cash
• Liabilities run 0.25x equity — within a conventional range